Q1 2022 Holdings
Filed 2022-05-16 | 96 holdings | $1.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $2.1K | 504,505 | 0.0% |
| Tscan Therapeutics Inc(TCRX) | COM | 89854M101 | $2.9K | 1,021,764 | 0.0% |
| Phasebio Pharmaceuticals Inc | COM | 717224109 | $3.8K | 2,850,000 | 0.0% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $5.2K | 1,281,860 | 0.0% |
| Health Sciences ACQ Corp 2 | ORD SHS | G4411D109 | $6.2K | 625,000 | 0.0% |
| Entera BIO LTD(ENTX) | SHS | M40527109 | $6.8K | 2,353,000 | 0.0% |
| Orchard Therapeutics PLC | ADS | 68570P101 | $6.9K | 9,694,789 | 0.0% |
| Verve Therapeutics Inc | COM | 92539P101 | $7.1K | 310,284 | 0.0% |
| 5 01 Acquisition Corp | COM CL A | 33836P105 | $7.4K | 750,000 | 0.0% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $8.5K | 1,262,193 | 0.0% |
| Pyxis Oncology Inc(PYXS) | COM | 747324101 | $9.2K | 2,282,173 | 0.0% |
| Arya Sciences Acquisitn | CLASS A ORD SHS | G31658100 | $9.7K | 1,000,000 | 0.0% |
| Allovir Inc | COM | 019818103 | $9.7K | 1,440,525 | 0.0% |
| IO Biotech Inc(IOBT) | COM | 449778109 | $9.8K | 1,857,755 | 0.0% |
| Frazier Lifesciences Acqu Co | CL A SHS | G3710A121 | $10.0K | 1,000,000 | 0.0% |
| Concert Pharmaceuticals Inc(CNCEEUR) | COM | 206022105 | $10.2K | 3,033,603 | 0.0% |
| Akouos Inc | COM | 00973J101 | $10.8K | 2,281,249 | 0.0% |
| Morphic Hldg Inc | COM | 61775R105 | $11.2K | 278,874 | 0.0% |
| Bcls Acquisition Corp | COM CL A | G0904B105 | $12.3K | 1,250,000 | 0.0% |
| Cyteir Therapeutics Inc | COM | 23284P103 | $12.6K | 3,350,506 | 0.0% |
| Otonomy Inc | COM | 68906L105 | $13.4K | 5,600,000 | 0.0% |
| Graphite BIO Inc(GRPH) | COM | 38870X104 | $13.8K | 2,698,369 | 0.0% |
| Xilio Therapeutics Inc(XLO) | COM | 98422T100 | $14.2K | 2,002,217 | 0.0% |
| Milestone Pharmaceuticals in(MIST) | COM | 59935V107 | $14.4K | 2,246,503 | 0.0% |
| Da32 Life Scnce TEC Acqstn C | CLASS A COM | 23312M106 | $14.6K | 1,500,000 | 0.0% |
| Achilles Therapeutics PLC(698) | SPONSORED ADS | 00449L102 | $14.7K | 5,014,687 | 0.0% |
| Solid Biosciences Inc | COM | 83422E105 | $14.8K | 12,367,873 | 0.0% |
| Kala Pharmaceuticals Inc | COM | 483119103 | $15.0K | 10,874,613 | 0.0% |
| Scpharmaceuticals Inc(SCPH) | COM | 810648105 | $15.1K | 2,658,583 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $15.6K | 7,775,207 | 0.0% |
| Synlogic Inc | COM | 87166L100 | $16.0K | 6,666,666 | 0.0% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $16.4K | 1,000,000 | 0.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $16.4K | 549,055 | 0.0% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $17.1K | 2,250,000 | 0.0% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $18.7K | 4,965,769 | 0.0% |
| Werewolf Therapeutics Inc(HOWL) | COM | 95075A107 | $18.9K | 4,291,881 | 0.0% |
| Connect Biopharma Hldgs LTD | ADS | 207523101 | $21.1K | 6,991,003 | 0.0% |
| Satsuma Pharmaceuticals Inc | COM | 80405P107 | $22.5K | 5,914,252 | 0.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $25.4K | 2,613,623 | 0.0% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $25.4K | 5,100,000 | 0.0% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $27.0K | 2,805,045 | 0.0% |
| Lianbio | SPONSORED ADS | 53000N108 | $28.4K | 7,655,015 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $28.5K | 1,930,322 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $29.0K | 1,155,964 | 0.0% |
| Guardant Health Inc(GH) | COM | 40131M109 | $31.6K | 476,380 | 0.0% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $32.1K | 3,577,094 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $33.4K | 2,107,149 | 0.0% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $35.3K | 2,186,636 | 0.0% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $35.6K | 1,710,265 | 0.0% |
| Rxsight Inc(RXST) | COM | 78349D107 | $37.8K | 3,052,796 | 0.0% |